Preliminary Results of HDR Brachytherapy of Cervical Carcinoma with Twice Daily

张新忠,吴畏,宋宏羽,李黎军,潘洁森,程媛,郎锦义

DOI: https://doi.org/10.3969/j.issn.1673-7555.2007.08.001

2007-01-01

Abstract:Objective To apply unconventional fractionation to intracavitary brachytherapy,explore the possibility and biological effect in clinic.Methods 65cases①For stageⅡb,tumor dose was 40 Gy in 4 wks(20fractions);for stageⅢb,tumor dose was46Gy in4.6wks(23fractions);②Afterwards,patients were irradiated by4fields with central shielding(Pb5HVL3～4cmwide),anterial and posterial portals to give a boost dose of 12～16 Gy.1.2～1.5Gy.1.2～1.5W(point B).Intracavitary therapy was given with HDR(point A).③(Ⅱb、Ⅲb)received 3.3 Gy perfraction,twice daily of intracavitary irradiation at point A.The intrafraction interval was more than 6 hours in one day.The total dose at point A was 1980 cGy in six fractions.3 day.1.5 wks.④At the same time of central shielding,external irradiation,HDR-intracavitary brachytherapy was carried on alternately.Results Early vagina reaction(modified Fowler’s skin reactions)was as follows:Ⅰ°40 cases(62%),Ⅱ°19 cases(30%) and Ⅲ°6 cases(8%),The reaction did not cause any break-up of treatment.By the end of radiotherapy,local control was as follows:CR52 cases(80%),PR13 cases(20%),NC0 case,PD0 case.All65cases are surviving well nowwith follow-up,In follow-up local recurrence has not been observed,hematuria and bloody stool have not been complained.Conclusion The enough fractionation including fraction number and dose per fraction were very important for impoving treatment effect and decreasing late complications of the HDR intracavitary brachytherapy for cervix carcinoma.We think that the method above was applicable as it proved satisfactory early effects.Further follow-up is needed to evaluate its survival rate as well as late tissue injury.